Research Findings from Shenzhen University Update Understanding of Pharmaceutical Biology (Long-term toxicological studies on the Chinese medicine 2036 Specialty-Qiangxin recipe in rats)

摘要

2021 SEP 21 (NewsRx)-By a News Reporter-Staff News Editor at Disease Prevention Daily-Investigators publish new report on pharmaceutical biology. According to news reporting out of Shenzhen University by NewsRx editors, research stated, "The traditional medicine 2036 Specialty-Qiangxin recipe (2036S-QXR) has been widely used in China to improve cardiac function, prevent stroke, and strengthen the immune system. However, its long-term toxicity remains unknown." Funders for this research include National Natural Science Foundation of China; Natural Science Foundation of Guangdong Province; Science and Technology Planning Project of Shenzhen Municipality; SZU Top Ranking Project; Shenzhen 'Sanming' Project of Medicines. The news correspondents obtained a quote from the research from Shenzhen University: "The present study evaluates the long-term toxicity of 2036S-QXR in rats. 2036S-QXR (0.6, 1.2, and 2.4 g/kg body weight per day) was orally administered for 26 weeks to Wistar rats, while the rats in the control group received distilled water. The effects on urinary, hematological, biochemical, and histopathological parameters were investigated during the study period. No significant changes in all tested parameters were observed in the 0.6 and 1.2 g/kg groups, compared with the control group (p <0.05).